Media stories about Imprivata (NYSE:IMPR) have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. Accern scores the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Imprivata earned a news sentiment score of 0.09 on Accern’s scale. Accern also gave media stories about the technology company an impact score of 45.9671190414347 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Imprivata has a 12-month low of $9.00 and a 12-month high of $19.28.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Watch List News and is the property of of Watch List News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.watchlistnews.com/imprivata-impr-given-news-impact-rating-of-0-09/1769590.html.

About Imprivata

Imprivata, Inc (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure.

Insider Buying and Selling by Quarter for Imprivata (NYSE:IMPR)

Receive News & Ratings for Imprivata Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imprivata and related companies with MarketBeat.com's FREE daily email newsletter.